Oxidation of meloxicam by Streptomyces griseus

Iranian Journal of Biotechnology

Volumn 7, Issue 3, 2009, Pages 142-147

  Gurram, Shyam Prasad ^a   Rama, Preethi ^a   Sivadevuni, Girisham ^a   Solipuram, Madhusudan Reddy ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

5 carboxy meloxicam streptomyces griseus; 5 hydroxymethyl meloxicam; Biotransformation; Meloxicam

Indexed keywords

5 CARBOXY MELOXICAM; 5 HYDROXYMETHYL MELOXICAM; DRUG METABOLITE; MELOXICAM; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CELL CULTURE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; NONHUMAN; OXIDATION; STREPTOMYCES; STREPTOMYCES GRISEUS; STREPTOMYCES LAVENDULAE; STREPTOMYCES RIMOSUS; TANDEM MASS SPECTROMETRY;

ACTINOBACTERIA (CLASS); STREPTOMYCES GRISEUS;

EID: 70350703096     PISSN: 17283043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alarcon J, Joel B, Alderete, Aguila S, Peter M (2005). Regio and stereo selective hydroxylation of A-Agarofuran by biotransformation of Rhizopus nigricans. J Chil Chem Soc. 50: 715-718.
2. Azerad R. (1999) Microbial models for drug metabolism. Adv Biochem Eng Biotechnol. 63: 169-218.
3. Busch U, Schmid J, Heinzel G, Schmaus H (1998). Pharmacokinetics of meloxicam in animal with relevance to humans. Drug Met Disp. 26: 576-584. (Pubitemid 28498364)
4. Chesne C, Guyomard C, Guillouzo A, Schmid J, Ludwig E, Sauter T (1998). Metabolism of meloxicam in human liver involves cytochromes P450 2C9 and 3A4. Xenobiotica 28: 1-13. (Pubitemid 28051312)
5. Chien M, Rosazza JP (1981). Microbial transformations of natural antitumor agents. 15. Metabolism of bruceantin by Streptomyces griseus. J Chem Soc Perkin Trans. 1: 1352-1356.
6. Chun YJ, Shimada T, Waterman MR, Guengerich FP (2006). Understanding electron transport systems of Streptomyces cytochrome P450. Biochem Soc Trans. 34: 1183-1185. (Pubitemid 46769017)
7. Devis HG, Green RH, Kelly DR, Roberts SM (1989). Biotransformations in preparative organic chemistry. Academic Press, London.
8. Dingler C, Ladner W, Krei GA, Copper B, Hauer B (1996). Preparation of (R)-2-(4-hydroxyphenoxy) propionic acid by biotransformation. Pesticide Sci. 46: 32-35. (Pubitemid 126759735)
9. Elbary AA, Foda N, Elkhateeb M (2001). Reversed phase liquid chromatographic determination of meloxicam in human plasma and its pharmacokinetic application. Anal Lett. 34: 1175-1187. (Pubitemid 32643238)
10. Engelhardt G, Homma D, Chilegel K, Utzmann R, Schnitzler C (1995b). Anti-inflamatory, analgesic, anti pyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res. 44: 423-433.
11. Gaisser S, Lill R, Staunton J, Mendez C, Salas J, Leadlay PF (2002). Parallel pathways for oxidation of 14-membered poly ketide macrolactones in Saccharopolyspora erythraea. Mol Microbiol. 44: 771-781. (Pubitemid 34526587)
12. Guruswamy S, Kumar V, Mishra DN (2006). Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Pharm Soc Japan. 126: 93-97.
13. Hosie J, Distel M, Bluhmki E (1996). Meloxicam in osteroarthritis: a 6-month double blind comparision with diclofenac sodium. British J Rheum. 35: 39-43.
14. Hu S, Tian X, Zhu W, Fang Q (1996). Microbial transformation of taxoids: Selective deacetylation and hydroxylation of 2α, 5α, 10β, 14β-tetra-acetoxy-4(20), 11-taxadiene by the fungus Cunninghamella echinulata Tetrahydron Lett. 52: 8739-8746.
15. Hu S, Tian X, Fang Q (1997). Selective microbial hydroxylation and biological rearrangement of taxoids Tetrahedron Lett. 38: 2721-2724.
16. th ed., Part 3, John Wiley & Sons, Inc., New York. PP. 699-758.
17. Kunz DA, Reddy GS, Vatvars A (1985). Identification of Transformation Products Arising from Bacterial Oxidation of Codeine by Streptomyces griseus. Appl Environ Microbiol. 50: 831-836.
18. Lonza (1992). Process for the production of 6-hydroxynicotinic acid. US patent No. 5082777.
19. Mazier C, Jaouen M, Agnès SM, Buisson D (2004). Microbial oxidation of terfenadine and ebastine into fexofenadine and care-bastine. Bioorg Med Chem Lett. 14: 5423-5426. (Pubitemid 39348938)
20. Mobic ®. Product Information, Boehringer Ingelheim Taiwan Ltd., Taiwan.
21. Patel RN (2000). Stereoselective biocatalysis for the synthesis of some chiral pharmaceutical intermediates. In: Stereoselective Biocatalysis, Patel RN, Marcel Dekker. ed., New York Basel p932. PP. 932.
22. Price BJ, Roberts SM (1985). Medical chemistry: The role of organic chemistry in drugs research, Academic Press, Orlando. PP. 196.
23. Reginster JY, Distel M, Bluhmki E (1996). A double blind three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis. British J Rheuma. 35: 17-21. (Pubitemid 26136670)
24. Rosazza JP, Kammer M, Youel L, Smith RV, Erhardt PW, Truang DH, Leslie SW (1977). Microbial models for mammalian metabolism. O-Demethylation of papaverine. Xenobiotica 7: 133-143.
25. Sariaslani FS, Mc Gee LR, Ovenall DW (1987). Microbial transformation of precocene II: oxidative reactions by Streptomyces griseus. Appl Environ Microbiol. 53: 1780-1784.
26. Sariaslani FS, Mc Gee LR, Trower MK, Kitson FG (1990). Lack of regio- and stereospecificity in oxidation of (+) camphor by Streptomyces griseus enriched in cytochrome P-450soy. Biochem Biophys Res Commun. 170: 456-461.
27. Sariaslani FS, Rosazza JP (1985). Biotransformations of 1, 2-dihydrorotenone by Streptomyces griseus. Appl Environ Microbiol. 49: 451-452.
28. Schmid J, Busch U, Henizel G, Bozler G, Kasehke S, Kummer M (1995a). Meloxicam pharmocokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects. Drug Metab Dispos. 23: 1206-1213.
29. Schmid J, Busch U, Trummitz G, Prox G, Kaschke S (1995b). Wachsmuth Meloxicam: metabolic profile and biotransfomation products in the set. Xenobiotica 25: 1219-1236.
30. Smith RV, Rosazza JP (1974). Microbial models for mammalian metabolism aromatic hydroxylation. Arch Biochem Biophys. 161: 551-558.
31. Torimura H, Yoshida H, Kano K, Ikeda T, Nagasawa T, Ueda T (1998). Bioelector chemically accelerated microbial conversion of nicotinic acid to 6-hydroxynicotinic acid on microorganisms immobilized column electrolytic flow system. Chem Lett. 27: 295-296. (Pubitemid 128101957)
32. Venisetty RK, Ciddi V (2003). Application of microbial biotransformation for the new drug discovery using natural drugs as substrates. Curr Pharm Biotechnol. 4: 123-140.